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Abstract
Background: Methylation of histone H4 on lysine 20 plays critical roles in chromatin structure and function via mono-
(H4K20me1), di- (H4K20me2), and trimethyl (H4K20me3) derivatives. In previous analyses of histone methylation dynamics
in mid-gestation mouse embryos, we documented marked changes in H4K20 methylation during cell differentiation. These
changes were particularly robust during myogenesis, both in vivo and in cell culture, where we observed a transition from
H4K20me1 to H4K20me3. To assess the significance of this change, we used a gain-of-function strategy involving the lysine
methyltransferases SUV420H1 and SUV420H2, which catalyze H4K20me2 and H4K20me3. At the same time, we
characterized a second isoform of SUV420H1 (designated SUV420H1_i2) and compared the activity of all three SUV420H
proteins with regard to localization and H4K20 methylation.
Principal Findings: Immunofluorescence revealed that exogenous SUV420H1_i2 was distributed throughout the cell, while
a substantial portion of SUV420H1_i1 and SUV420H2 displayed the expected association with constitutive heterochromatin.
Moreover, SUV420H1_i2 distribution was unaffected by co-expression of heterochromatin protein-1a, which increased the
targeting of SUV420H1_i1 and SUV420H2 to regions of pericentromeric heterochromatin. Consistent with their
distributions, SUV420H1_i2 caused an increase in H4K20me3 levels throughout the nucleus, whereas SUV420H1_i1 and
SUV420H2 facilitated an increase in pericentric H4K20me3. Striking differences continued when the SUV420H proteins were
tested in the C2C12 myogenic model system. Specifically, although SUV420H1_i2 induced precocious appearance of the
differentiation marker Myogenin in the presence of mitogens, only SUV420H2 maintained a Myogenin-enriched population
over the course of differentiation. Paradoxically, SUV420H1_i1 could not be expressed in C2C12 cells, which suggests it is
under post-transcriptional or post-translational control.
Conclusions: These data indicate that SUV420H proteins differ substantially in their localization and activity. Importantly,
SUV420H2 can induce a transition from H4K20me1 to H4K20me3 in regions of constitutive heterochromatin that is sufficient
to enhance myogenic differentiation, suggesting it can act an as epigenetic ‘switch’ in this process.
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Introduction
An essential component of chromatin biology involves the post-
translational modification of the core histones H2A, H2B, H3 and
H4. This can involve the addition of acetyl, methyl, phosphate,
ADP-ribosyl, or ubiquitin moieties to over 30 target sites, which is
further extended by the placement of multiple methyl groups on
lysine and arginine [1,2,3,4]. In the case of lysine methylation, this
involves the transfer of up to three methyl groups from S-adenosyl-
methionine to create mono-, di-, and trimethyl derivatives [5,6].
These lysine modifications are limited to histones H3, where they
can occur on multiple residues, and H4, which contains a single
target site at position 20 (H4K20) [6]. In metazoans, the formation
of H4K20me1 is catalyzed by PR-Set7/KMT5A [7,8], while
H4K20me2 is generated primarily by SUV420H1/KMT5B
(which can also produce H4K20me3) and H4K20me3 by
SUV420H2/KMT5C [9,10,11]. At the cellular level, knockdown
of PR-Set7 is associated with mitotic defects and an inability to
undergo chromosome condensation, and its targeted ablation in
mice is embryonic lethal [12,13,14,15,16,17]. In contrast, mice
deficient for Suv420h2 are viable [11], although mouse embryonic
fibroblasts lacking this enzyme exhibit defects in telomere
maintenance, which is consistent with the accumulation of
H4K20me3 in telomeric heterochromatin [18]. Lastly, Suv420h1
knockout mice die perinatally and show overall growth retardation
[11], indicating that the three histone H4-K20 methyltransferases
(KMTs) have distinct functions in vivo.
Together with KMT loss-of-function studies, biochemical, cell
biological, and genetic analyses also suggest that the three methyl
states of histone H4K20 confer distinct functions (reviewed in
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distributions within interphase and mitotic nuclei, as well as along
chromatin fibers, and exhibit differences during the cell cycle
[9,20]. Specifically, H4K20me1 undergoes a modest elevation
during S phase, but is markedly increased as cell progress from G2
through mitosis. This is contrasted by H4K20me2, which is lowest
in G2 and achieves its maximum in G1 where it accounts for
.90% of K20-methylated histone H4. The least abundant
derivative, H4K20me3, undergoes only modest changes during
the cell cycle [9]. Nevertheless, the trimethyl derivative of histone
H4K20 exhibits marked changes during cell differentiation and
ageing [21,22]. Specifically, analyses in mid-gestation mouse
embryos reveal a marked elevation of H4K20me3 in muscle and
neural lineages and a corresponding decrease in H4K20me1 as
cells became post-mitotic [21]. These findings suggest that the
balance of histone H4K20 methylation states is important in the
transition from cell proliferation to differentiation, which is further
supported by the decrease in H4K20me3 that occurs in
malignancy [23,24,25].
To address the potential role of histone H4K20 methylation in
cellular differentiation, we used a gain-of-function strategy to
characterize the SUV420H proteins during myogenesis. At the
same time, this provided an opportunity to assess potential
differences in the activity of SUV420H1 and SUV420H2, as well
as associated splice forms. In particular, SUV420H1 comprises
two forms, designated SUV420H1_i1 and SUV420H1_i2, where
the latter corresponds approximately to the amino-terminal half of
the former and has not been previously characterized. We found
that SUV420H proteins differed in their activity at the cellular
level and that manipulating histone H4K20 methylation had
marked effects on cell differentiation.
Methods
Plasmids and RT-PCR
Full-length human SUV420H1_v1, SUV420H1_v2 and SUV420H2
cDNAs (Mammalian Gene Collection; purchased from Open
Biosystems) were subcloned into pEGFP-C1 (BD BioScience),
pEGFP-N1 (BD BioScience), and pCI (Promega) that had been
modified to encode an amino-terminal hemagglutinin-A epitope tag.
In each case, open reading frames were amplified by PCR and their
integrity was confirmed by sequencing. A similar approach was used
to produce GPF-HP1a (pEGFP-C1) and DsRed2-HP1a (pDsRed2-
C1; BD Bioscience) expression plasmids. Gene and protein
annotations are based on the Human Genome Nomenclature
Committee guidelines (http://www.genenames.org/guidelines.html).
Cell Culture and Transfection
Mouse C2C12 myoblast cells and C3H 10T1/2 fibroblasts were
acquired from the American Type Culture Collection and
cultured in DMEM supplemented with 4 mM L-glutamine and
either 10% (10T1/2) or 15% FBS (C2C12), which for the latter
was designated as growth media (GM). All cells were cultured at
37uC with 5% CO2 and transfected at 50%–80% confluency. To
characterize SUV420H localization and affects on histone H4K20
methylation, cells were transiently transfected with expression
plasmids using PEI transfection reagent (Polysciences, Inc.). For
immunofluorescence, cells were seeded on glass cover slips in 6-
well plates at a density of ,1.0610
6 cells/ml. After 24 hrs, cells
were transfected using an empirically optimized PEI:DNA ratio of
5:1. For C2C12 cells, 200 ml of serum-free DMEM was added to
1 mg of plasmid DNA, at which point 5 ml of PEI transfection
reagent was added and the contents were mixed by ‘vortexing’ for
10s. The same procedure was used for C3H 10T1/2 cells except
that 67 ml of serum-free DMEM was added to 1 mg of plasmid
DNA. The PEI:DNA mixture was incubated at room temperature
for 15 min and then added drop-wise to cover slips that had been
washed twice with 2 ml of d-PBS. Cells were processed for
immunofluorescence after 24 hrs. For co-transfection of 10T1/2
cells with SUV420H and HP1a,1mg of each expression plasmid
was used. For differentiation experiments, transfections were
carried out using Fugene reagent (Roche). Cells were plated onto
ethanol-sterilized glass cover slips so that they were 50 to 80%-
confluent the following day and then transfected with 1 mgo f
specified plasmid construct at a 6:1 Fugene:DNA ratio according
to the manufacturer’s instructions. To induce differentiation of
C2C12 cells, GM was replaced with DMEM containing 2% horse
serum (designated as differentiation media; DM). For time course
experiments, cells were transferred to DM 24 hrs post-transfection
(assigned as day 0) and then analyzed at 24 hr intervals from days
1 to 5 with media changes every 2 days.
Immunofluorescence and epifluorescence microscopy
Cells on cover slips were washed with phosphate-buffered saline
(PBS) and fixed with freshly prepared 4% paraformaldehyde for
5 min at room temperature, followed by three 5 min PBS washes.
For cells transfected with GFP expression plasmids, cover slips
were mounted onto glass slides with 20 ml of Mowoil containing
1 mg/ml Hoechst 33258 (Sigma); for immunofluorescence, cells
were first permeabilized with 1% TritonX-100 in PBS for 10 min
at room temperature. After three 5 min washes in PBS, cells were
blocked using 5% BSA in PBS for 1 hr at 4uC, rinsed 3 times with
PBS containing 1% BSA, and then incubated with primary
antibody (rabbit a-H4K20me3 (AbCam), 1:100; rabbit a-
H4K20me2 (AbCam), 1:200; rabbit a-H4K20me1 (AbCam),
1:250; mouse a-HA (Covance), 1:1000; rabbit a-HA (AbCam),
1:200; and mouse a-F5D (Developmental Studies Hybridoma
Bank), 1:100) for 1 hr at room temperature. Cells then underwent
three 5 min washes with PBS containing 1% BSA prior to
incubation with fluorescent secondary antibody (a-mouse
Alexa594, 1:400; a-mouse Alexa488, 1:400; a-rabbit Alexa594,
1:400 (Molecular Probes)) and incubated at room temperature for
1 hr in the dark. Last, cover slips were washed three times for
5 min with PBS and then mounted as above. For differentiation
experiments, cells were fixed, permeabilized, and immunostained
using the a-F5D antibody together with aHA antibody, or no
antibody if using GFP-fusion proteins.
Image collection and analysis
To quantify Myogenin and SUV420H co-expression during
C2C12 differentiation, cells were visualized using a Leica DMRE
fluorescence microscope. Images were captured with a mono-
chrome 10-bit CCD camera (Qimaging) and collected with
Northern Eclipse v6.0 software (Empix Imaging Inc.). Cells were
manually counted and data was exported to Excel (Microsoft)
where quantitative analyses were performed. High resolution
images were acquired on a Zeiss Axioplan 2 microscope equipped
with a 12-bit CoolSnap HQ cooled CCD camera (Roper Scientific
Inc.). Images were captured using Metamorph 7.5 (Molecular
Devices) and deconvolved using Huygens Essentials Deconvolu-
tion software (Scientific Volume Imaging). Image reconstruction
was performed using Imaris (Bitplane AG).
Protein extracts and western blotting
For the preparation of protein extracts, cells were recovered via
centrifugation (1 min at 13,000 rpm) at room temperature and
resuspended in 250 ml of cold lysis buffer containing 50 mlo f
proteinase inhibitor cocktail (Mammalian PIC, Sigma) and 10 ml
SUV420H Proteins in Myogenesis
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incubation on ice, lysis was completed by sonication (two 10s
pulses) and cellular debris was removed by centrifugation at
13,000 rpm for 10 min at 4uC. To prepare acid extracted
histones, 10T1/2 cells were detached from 15 cm tissue culture
plates by treatment with PBS containing 0.53mmol/l EDTA
(10 min at 37uC). Cells were recovered by centrifugation at
1,500 rpm for 5 min (4uC) and washed three times with cold PBS
prior to lysis in cold histone acid extraction buffer (1 min at room
temperature). Nuclei were harvested by centrifugation at 3,0006g
for 1 min, resuspended in 570 ml sterilized water containing 6.4 ml
of 4N H2SO4, and left on ice for 30 min. Nuclear debris was
separated from acid-soluble nuclear proteins by centrifugation.
The supernatant was transferred to 60 ml of Tris-HCl buffer
(pH 8.0) containing 40 ml of 10N NaOH and mixed by vortexing.
Protein separation was achieved by SDS-PAGE using either 15%
(histone extracts) or 10% (whole cell extracts) separating gels.
Protein concentration was determined by Bradford assay and
equivalent quantities of protein were resolved and transferred to
PVDF membranes, which were then blocked (2 hrs at room
temperature) in PBS containing either 5% nonfat milk, 10%
nonfat milk, or 5% BSA depending on the antibody. Primary
antibody dilutions were as follows: a-H4K20me1, 1:500 in 5%
BSA (AbCam); a-H4K20me2, 1:1000 in 10% milk (Upstate), a-
H4K20me3, 1:750 in 5% BSA (AbCam); and mouse a-HA,
1:2000 in 5% milk (Covance). Following an overnight incubation
at 4uC, blots were washed 4 times (10 min) in TBST and
incubated with secondary antibody (1 hr at room temperature): a-
rabbit HRP (1:5000) or a-mouse HRP (1:5000 (Cedarlane)). Blots
were washed 4 times with Tris-Buffered-Saline-Tween (TBST) for
10 min and then underwent a final rinse with TBS lacking Tween-
20. Chemiluminescence was performed as per the manufacturer’s
instructions (Amersham Biosciences) using Kodak Biomax film.
Results
The SUV420H1 gene encodes a second highly conserved
isoform
Genetic screens for novel regulators of position-effect-variega-
tion (PEV) in Drosophila led to the discovery of suv420, a member of
the SET-domain family of lysine methyltransferases (KMTs), and
facilitated the identification of two mammalian homologues,
SUV420H1 and SUV420H2 [10]. Although genetic and bio-
chemical data support the ability of these KMTs to trimethylate
histone H4-lysine 20 (H4K20me3) in vitro and in transfected cells
[10,26], SUV420H1 appears largely responsible for the catalysis of
H4K20me2 in vivo, while SUV420H2 activity accounts for the
production of H4K20me3 [11,26]. In the current study, we have
examined how differences in the primary structure of these KMTs
influence their biological activity. Importantly, we have included a
second SUV420H1 isoform that is annotated in NCBI Build36 of
the human genome. This protein (referred to as SUV420H1_i2) is
identical to the canonical form (designated SUV420H1_i1) over
the first 391 residues and arises by retention of an intron that
creates an alternatively spliced mRNA encoding only two
additional amino acids (Figure 1A). As a result of this truncation,
SUV420H1_i2 contains the catalytic SET domain and two
additional regions of homology (Figure 1A, filled boxes), but lacks
a third segment that is present in both SUV420H1_i1 and
SUV420H2 (Figure 1A, gray box).
As a first step in evaluating the authenticity of the
SUV420H1_i2 isoform, we sought to establish its evolutionary
conservation. To this end, multiple genome databases (HTGS,
GSS, WGS; 36 species in total) were queried and sequence
alignments were carried out using the region that spans the exon
9-intron 9 junction (Figure 1B and Figure S1A). This revealed
perfect conservation of the splice donor with only one occurrence
of an atypical GA splice site (Dasypus novemcinctus). Similarly,
conservation of the stop codon is also clearly evident, being present
in 32 of 36 sequences (Figure 1B and Figure S1A). The only
exceptions were Gallus gallus, Anolis carolinensis, Monodelphis domestica,
and Xenopus tropicalis, which retain the splice site but encode an
additional 4, 16, 17, or 20 amino acids before encountering a stop
codon. Importantly, analysis of the Expressed Sequence Tag (EST)
database indicated that the SUV420H1_v2 mRNA is generated in
vivo and was detected in multiple tissues from diverse species (data
for mouse and human is shown in Figure S1C). Lastly, homology
included the 39-UTR, where there was a region of conservation
downstream of exons 9 (39-UTR for SUV420H1_v2) and 10 (39-
UTR for SUV420H1_v1) that was not observed flanking other
exons of the SUV420H1 gene (Figure S1B). Based on the
widespread conservation of the shorter SUV420H1_i2 protein,
this isoform was used in comparative analyses together with
SUV420H1_i1 and SUV420H2 to assess their localization and
activity in situ.
The SUV420H1_i2 isoform exhibits a localization that is
distinct from SUV420H1_i1 and SUV420H2
Initial description of the SUV420H proteins focused on
SUV420H1_i1 and SUV420H2, and found that both localize to
regions of pericentromeric heterochromatin (PCH) [10]. In each
case, deletion analyses implicated the carboxy-terminus, which is
absent from SUV420H1_i2, in conferring this distribution [10].
To evaluate the impact of these differences in primary structure on
cellular distribution, we employed immunofluorescence to com-
pare the localization of both SUV420H1 isoforms and
SUV420H2. For this purpose, derivates of each KMT were made
that contained an amino-terminal HA epitope tag (Figure 2A,
upper), as well as versions containing GFP fused to the amino or
carboxy-terminus (Figure 2A, lower), and sizes were verified by
western blotting. In these experiments, SUV420H1_i1 was
consistently expressed at a lower level than either SUV420H1_i2
or SUV420H2, but could be detected by immunofluorescence
(addressed below) where it displayed a 2 to 3-fold lower
transfection efficiency. Upon examining the cellular distribution
of each KMT, they exhibited multiple localization patterns that
included PCH, diffuse nuclear staining, or simultaneous presence
in both the nucleus and the cytoplasm (Figure 2B).
The current model for localization of SUV420H proteins
involves their recruitment to constitutive heterochromatin through
a direct interaction with HP1a via its binding to H3K9me3 [10].
Accordingly, cells lacking H3K9me3 in constitutive heterochro-
matin owing to a knockout of the underlying KMTs, Suv39h1 and
Suv39h2, also lack H4K20me3 in these domains [10]. The
distribution of each SUV420H protein was therefore quantified
in the absence or presence of HP1a co-expression (Figure 2C-2E).
As expected, exogenous SUV420H1_i1 (Figure 2C) and
SUV420H2 (Figure 2E) displayed PCH distribution, but were
also characterized by a fraction of cells with a diffuse nuclear
pattern and a smaller percentage of cells that exhibited
cytoplasmic staining. These latter fractions were consistently
greater for SUV420H2 and may relate to its higher expression
level (Figure 2A). In contrast, SUV420H1_i2 only exhibited diffuse
cytoplasmic or nuclear distribution (Figure 2D). Interestingly, co-
expression of HP1a caused the redistribution of SUV420H1_i1
(Figure 2C) and SUV420H2 (Figure 2E) such that nearly all
(.90%) co-transfected cells displayed localization to PCH. As a
result, the cytoplasmic or diffuse nuclear distributions likely occur
SUV420H Proteins in Myogenesis
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endogenous capacity of HP1 proteins to direct PCH localization.
The distribution of SUV420H1_i2, however, was largely unaf-
fected by HP1a expression, although there was a trend towards an
increased ‘nuclear diffuse’ fraction (Figure 2D). Together, these
observations indicate that while HP1a is rate limiting for
localization of SUV420H1_i1 and SUV420H2 to constitutive
heterochromatin, SUV420H1_i2 is under distinct control and
lacks determinants for PCH localization.
SUV420H1_i2 differs from SUV420H1_i1 and SUV420H2
in where it catalyzes H4K20me3
Given the marked differences in localization of SUV420H1_i2 in
comparison to SUV420H1_i1 and SUV420H2, we sought to
determine if these influence the nuclear distribution of their
methylated products. As a first step, we assessed the affect of
exogenous SUV420H expression on global levels of histone H4-K20
methyl derivatives by western blotting (Figure 3), which indicated
each enzyme could induce an increase in H4K20me3 levels that was
proportional to their relative transfection efficiency (SUV420H2.-
SUV420H1_i2&SUV420H1_i1). For both SUV420H1_i2 and
SUV420H2, we also observed a corresponding decrease in
H4K20me1 (Figure 3). Although this reduction was not apparent
with SUV420H1_i1, likely because of its lower overall expression
level (Figure 2A), its activity was clearly apparent in immunofluores-
cence experiments (addressed below). As we did not observe
differences in H4K20me2 levels upon SUV420H expression
(addressed in discussion), co-immunofluorescence studies focused on
analyses of H4K20me3 and H4K20me1. Exogenous expression of
SUV420H1_i1 (Figure 4A), SUV420H1_i2 (Figure 4B), and
SUV420H2 (Figure 4C) in C3H 10T1/2 mouse fibroblast cells
resulted in increased H4K20me3, regardless of localization pattern.
For SUV420H1_i1 and SUV420H2, transfected cells retained their
characteristic pattern of enrichment at PCH, but also displayed more
widespread H4K20me3 elevation. Consistent with its diffuse nuclear
localization,SUV420H1_i2causedamarkedincreaseinH4K20me3
throughout the nucleus with no obvious elevation in regions of
constitutive heterochromatin (Figure 4B). This further distinguished
the activity of this KMT from SUV420H1_i1 and SUV420H2, both
of which caused an increase in H4K20me3 in regions of PCH
(Figure 4A and C, compare a and b panels). As expected, H3K9me3
levels were unaltered in cells expressing any of the SUV420H
enzymes (data not shown). Lastly, we observed that expression of all
isoforms of SUV420H resulted in an obvious decrease in H4K20me1
throughout the nucleus, further supporting the notion that
H4K20me1 is the substrate for catalysis of H4K20me3 by all three
SUV420H proteins (Figure 5A-C) [9,11]. In addition, the fact that
the conversion of H4K20me1 to H4K20me3 occurs throughout the
nucleus indicates that the activity of SUV420H1_i1 (Figure 5A, lower
panels) and SUV420H2 (Figure 5C, lower panels) is not necessarily
Figure 1. Conservation of a second SUV420H1 isoform. A) Schematic overview of the SUV420H1 isoforms (SUV420H1_i1 and SUV420H1_i2)
and SUV420H2. All three SUV420H proteins contain the catalytic SET domain, as well as 2 additional regions of conservation (black boxes). The shorter
SUV420H1_i2 isoform lacks a 492 amino portion of SUV420H1_i1, which includes a short region of homology with SUV420H2 (gray box). B) Homology
of the exon 9-intron 9 splice junction is depicted with a WebLogo pictogram (weblogo.berkeley.edu) using sequences aligned from 36 metazoan
species (see Figure S1). As a result of alternative splicing, the SUV420H1_i2 protein is identical to SUV420H1_i1 over the first 391 amino acids and
encodes only two additional residues (‘S-K’), which are encoded by intron 9 and differ between the two isoforms.
doi:10.1371/journal.pone.0014447.g001
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enrichment of H4K20me1 that occursin facultative heterochromatin
on the inactive X chromosome (Figure 5A-C, labeled Xi in lower
panels) was also lost upon exogenous SUV420H expression.
Expression of GFP alone had no affect on levels of H4K20me1 or
H4K20me3 (Figure S2). These findings therefore indicate
SUV420H1_i2 differs in where it catalyzes H4K20me3 formation,
providing another parameter that is distinct from SUV420H1_i1and
SUV420H2.
SUV420H proteins have distinct affects on the
differentiation of C2C12 cells
We previously described an inverse relationship between
H4K20me1 and H4K20me3 in the myotome of mid-gestation
Figure 2. Expression and localization of recombinant SUV420H proteins. A) C3H 10T1/2 cells were transfected with expression plasmids
encoding SUV420H1_i1, SUV420H1_i2, and SUV420H2 with an N-terminal HA-tag or with GFP fused to either the N- or C-terminus. Representative
western blots are shown for HA-tagged (upper panel) and GFP versions of these KMTs (lower panel). SDS-PAGE was carried out with equivalent
amounts of total cellular protein (a GAPDH immunoblot is included as a loading control). With the exception of SUV420H1_i1-GFP, which could not
be detected, all recombinant proteins were of the expected size. B) Representative micrographs depict cytoplasmic, diffuse nuclear, or pericentric
heterochromatin localization for HA-SUV420H2. Gray scale images are shown for individual channels and the merged image depicts SUV420H2
(green) and DAPI (red). C-E) Each SUV420H protein was scored based on its localization (as in B) and the resulting data is shown in a bar graph (N,
nuclear; C, cytoplasm; and PCH, pericentromeric heterochromatin) in the presence or absence of HP1a co-transfection. Error bars represent standard
error of the mean from two independent experiments. The micrographs depict representative images of HA-SUV420H and GFP-HP1a co-expression.
Gray scale images are shown for individual channels and the merged image depicts SUV420H2 (red) and HP1a (green). Controls involving GFP/HP1a-
dsRED2 or dsRED2/HP1a-GFP established that the fluorescent protein moieties did not influence localization.
doi:10.1371/journal.pone.0014447.g002
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cultures. Specifically, H4K20me1 levels declined and those for
H4K20me3 increased during myogenic differentiation [21]. These
changes in histone H4-K20 methylation were also observed in the
C2C12 myogenic model system [21], which can be induced to
differentiate by switching cell cultures from regular growth media
(GM) to differentiation media (DM) containing 2% serum (see
Experimental Procedures). We therefore wanted to determine if
facilitating this transition in histone H4K20 methylation (see
Figures 4 and 5) had an impact on C2C12 cell differentiation. To
this end, C2C12 cells were transfected with SUV420H expression
plasmids and then assessed for the differentiation marker
Myogenin (Myog) by co-immunofluorescence at day 0 while still
in GM (24 hrs post transfection) or at days 1 to 5 after transfer to
DM. The percentage of Myog-positive cells was determined from
the population of non-transfected cells and cells expressing the
SUV420H protein. At the same time, three other parameters were
assessed: we determined overall transfection efficiency and
retention of transfected cells, as well as monitored the localization
of SUV420H proteins during the differentiation time course
(Figure 6). Paradoxically, this indicated that neither HA or GFP-
tagged SUV420H1_i1 could be efficiently expressed in C2C12
cells, despite being able to detect the recombinant protein in
10T1/2 cells by immunofluorescence (Figures 4 and 5) and
western blotting (Figure 2A, upper panel). Moreover, this inability
was also apparent 4 and 8 hrs post-transfection, suggesting the
protein is never made or is rapidly degraded, and it was therefore
not included in subsequent analyses. Of the two remaining
proteins, SUV420H2 was consistently characterized by higher
transfection efficiency than SUV420H1_i2 (20.9% versus 5.5% at
day 0) and a greater proportion of SUV420H2-transfected cells
were retained over the course of differentiation (5.4% versus
1.5%). This decline occurred from day 0 to day 2, after which the
fraction of transfected cells was stable. Together, these differences
suggest the exogenous SUV420H1 proteins are either deleterious
to the expressing cell or that their levels are tightly regulated.
In terms of localization, SUV420H1_i2 did not change from its
predominantly cytoplasmic distribution, which remained signifi-
cantly higher (p,0.05) than the nuclear fraction over the
differentiation time course (Figure 6A). On the other hand,
although SUV420H2 was similar at day 0 to that described in
10T1/2 cells (Figure 2E), the fraction of cells displaying
cytoplasmic or diffuse nuclear distribution declined while those
exhibiting localization to pericentric heterochromatin underwent a
significant increase (p,0.05) from day 0 to day 1, and continued to
increase throughout (Figure 6B). Similarly, with the exception of
day 0, the heterochromatic portion was significantly (p,0.05 to
p,0.005) elevated compared to nuclear and cytoplasmic fractions
at all time points.
Differences in the activity of SUV420H1_i2 and SUV420H2
continued upon examining their influence on C2C12 myogenesis.
We observed a similar percentage of Myog-positive cells over the
course of differentiation when considering only the non-transfect-
ed cells (,1% at day 0 and ,16% by day 5; Figure 7A and B). In
cells expressing SUV420H1_i2 (Figure 7A), however, there was an
increase in Myog-positive cells even prior to the addition of DM
(,5.5-fold), which suggests this enzyme can induce precocious
differentiation. Nevertheless, the situation changes in DM where
we observed a steady decline in SUV420H1_i2/Myog double
positive cells (,2% at day 5), while SUV420H2 expressing cells
maintained a higher fraction (,46% at day 5) of Myog-positive
cells than the bulk culture (compare Figure 7A to 7B). Express-
ing the data as the fold difference between double-positive cells
versus Myog single positives clearly illustrates the effects of
SUV420H1_i2 and SUV420H2. Despite inducing precocious
appearance of Myog, the ratio of Myog to Myog/SUV420H1_i2-
double positive cells steadily declines from 5.5 on day 0 to 0.12 on
day 5, representing an approximately 46-fold change. In contrast,
SUV420H2 maintained an increased population of double-
positive cells at all time points tested (2.2-fold on average). Thus,
even though SUV420H1_i2 and SUV420H2 have similar effects
on global levels of H4K20me1 and H4K20me3 when expressed
exogenously (Figures 4 and 5), they are associated with distinct
activities and only the latter supports enhanced differentiation.
Discussion
In mammalian cells, methylation of lysine 20 on histone H4 is
carried out by PR-Set7 (SETD8, SET8, KMT5A), SUV420H1
(KMT5B), and SUV420H2 (KMT5C) (reviewed in [19]). Although
the latter two display a high level of identity to each other (,58%
over the catalytic domain) and the Drosophila suv420h protein, they
aredistantlyrelatedtothe PR-Set7 protein inevolutionaryterms.In
the current study, we characterized a second SUV420H1 isoform,
designated SUV420H1_i2, and found it has markedly different
activity when compared to the originally described SUV420H1_i1
and SUV420H2 proteins. From a primary structure standpoint,
SUV420H1_i2 represents a truncated version of SUV420H1_i1
and is missing the carboxy terminal region that has been implicated
in interaction with HP1a and the RB1 tumor suppressor protein
[10,27,28]. Thisincludes a ‘PxVxL’ motif (PKVVL at position 480),
whichhas been shown toconferinteraction with HP1a innumerous
proteins [29]. The SUV420H2 protein contains a related PHCRL
sequence at position 364 that is present within a short region of the
protein known to confer interaction with HP1a and localization to
PCH [10,27,28]. Consistent with these features, the shorter
SUV420H1_i2 isoform did not localize to constitutive heterochro-
matin and its distribution was unaffected by HP1a co-expression,
suggesting that itfunctionsina distinct histone H4-K20methylation
pathway. The SUV420H1_i2 protein can be further distinguished
Figure 3. Western analysis of histone H4K20 methyl derivatives
following expression of exogenous SUV420H proteins. C3H
10T1/2 cells were transfected with HA-tagged expression plasmids for
SUV420H1_i1, SUV420H1_i2, and SUV420H2, and used for the
preparation of acid extracted histones. Equivalent amounts of histone
protein from SUV420H-transfected and untransfected cells were used in
western blotting with antibodies specific for H4K20me1, H4K20me2,
H4K20me3, or total histone H4. Expression of each SUV420H KMT led to
an increase in H4K20me3 levels that was proportional to the
transfection efficiency, a corresponding decrease in H4K20me1 for
SUV420H1_i1 and SUV420H2, and no affect on H4K20me2. It should be
noted that the H4K20me2 modifications accounts .80% of histone H4
methylated species in asynchronous cells [9], making it difficult to
detect modest changes in levels.
doi:10.1371/journal.pone.0014447.g003
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signals, likely accounting for its presence in the cytoplasm.
Moreover, these differences in carboxy-termini had a marked effect
on the expression of the two isoforms—SUV420H1_i1 was
expressed at lower levels in 10T1/2 cells and exogenous protein
could not be efficiently detected at anytime followingtransfection of
the C2C12 cell line. As a result, the carboxy-terminal segment of
SUV420H1_i1, or the mRNA sequence encoding it, may be subject
to post-translational or post-transcriptional control. In addition, the
SUV420H1_i2 protein could not achieve the same transfection
efficiency as SUV420H2 (in either 10T1/2 or C2C12), together
indicating that exogenous activity of the SUV420H1 proteins is less
tolerated, and may therefore affect cell cycle progression or survival.
Expression of individual SUV420H proteins led to increased
levels of H4K20me3 and a corresponding decrease in H4K20me1
when assessed by either immunofluorescence or western blotting.
This is consistent with PR-Set7 knockdown and gene-targeting
experiments that indicate H4K20me1 is a substrate for progressive
di- and trimethylation by the SUV420H proteins [9,11,17,26].
However, ablation of the Suv420h1 gene leads to a specific
decrease in H4K20me2 (and an increase in H4K20me1),
indicating that SUV420H1 acts primarily as a dimethylase in vivo
Figure 4. Affect of exogenous SUV420H expression on H4K20me3. C3H 10T1/2 cells were transfected with expression plasmids encoding
SUV420H1_i1, SUV420H1_i2, and SUV420H2 with an N-terminal HA-tag or with GFP fused to either the N- or C-terminus and processed for
immunofluorescence using antibodies specific for H4K20me3. Representative micrographs are shown for N-terminal GFP fusions of (A) SUV420H1_i1,
(B) SUV420H1_i2, and (C) SUV420H2. In each panel, 406field shots are shown that display grayscale images for SUV420H and H4K20me3, and the
corresponding merged image (SUV420H, green; H4K20me3, red). The lower panels depict representative transfected (a) or non-transfected (b) cells
that have been copied from the 406micrograph and include grayscale images for the recombinant enzyme and H4K20me3. Scale bars are 50 mm
(upper panels)o r1 0mm( lower panels).
doi:10.1371/journal.pone.0014447.g004
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SUV420H1 and SUV420H2 are capable of catalyzing
H4K20me3 and can also catalyze H4K20me3 in vitro from an
unmethylated substrate [10,26]. This flexibility in product
specificity is similar to that of Toxoplasma gondii PR-Set7 (a.k.a.
SETD8) [30] and S. pombe set9p, which can catalyze all three
histone H4-K20 methyl derivatives [31], and with the finding that
human PR-Set7 can be converted to a dimethylase with a single
amino acid substitution [32]. Second, in dividing cells where the
G1 population predominates, H4K20me2 already accounts for
,90% of histone H4-K20 methylated species [9]. As a result of its
overall abundance, it would be difficult to affect a substantive
increase in H4K20me2 levels and it therefore remains possible
that exogenous SUV420H1 expression may catalyze this modifi-
cation on a limited scale.
Expression of SUV420H1_i2 and SUV420H2 were associated
with distinct outcomes during myogenesis, despite both causing
elevated H4K20me3 and reduced H4K20me1. Nevertheless, the
two enzymes differed significantly in where they directed
H4K20me3. The widespread catalysis of H4K20me3 by
SUV420H1_i2 was associated with precocious appearance of
Myog in C2C12 cells, which is an early marker for myogenic
Figure 5. Affect of exogenous SUV420H expression on H4K20me1. C3H 10T1/2 cells were transfected with expression plasmids encoding
SUV420H1_i1, SUV420H1_i2, and SUV420H2 with an N-terminal HA-tag or with GFP fused to either the N- or C-terminus and processed for
immunofluorescence using antibodies specific for H4K20me1. Representative micrographs are shown for N-terminal GFP fusions of (A) SUV420H1_i1,
(B) SUV420H1_i2, and (C) SUV420H2. In each panel, 406field shots are shown that display grayscale images for SUV420H and H4K20me1, and the
corresponding merged image (SUV420H, green; H4K20me1, red). The lower panels depict representative transfected (a) or non-transfected (b) cells
that have been copied from the 406 micrograph and include grayscale images for the recombinant enzyme and H4K20me1. Enrichment of
H4K20me1 on the inactive X chromosome (Xi) is indicated. Scale bars are 50 mm( upper panels)o r1 0mm( lower panels).
doi:10.1371/journal.pone.0014447.g005
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PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e14447Figure 6. Localization of exogenous SUV420H proteins during myogenesis in C2C12 cells. The C2C12 myoblast cell line was transfected
with expression plasmids for SUV420H1_i2 (A) and SUV420H2 (B). The localization of recombinant proteins was monitored by immunofluorescence at
day 0 (d0; 24 hr post-transfection) in GM and over a 5 day (d1-d5) differentiation time course in DM. Graphs provide an overview of SUV420H
localization (C, cytoplasmic, gray bars; N, nuclear, open bars; or PCH, pericentromeric heterochromatin, closed bars). Data is plotted as a percentage
(Frequency) of total SUV420H-expressing cells displaying the indicated distribution from day 0 to day 5. Error bars represent standard deviation from
three independent experiments and significant differences are noted in the text. As noted in the text, we were unable to express SUV420H1_i1 in the
C2C12 cell line. The compiled data is based on the analysis of 56,939 (SUV420H1_i2) and 64,464 cells (SUV420H2).
doi:10.1371/journal.pone.0014447.g006
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initiated from the G1 phase of the cell cycle upon serum
withdrawal [34,35], which would coincide with peaks in
H4K20me2 and H4K20me3, and declining levels of H4K20me1
[9]. This acute change in histone H4-K20 methylation differs,
however, from the opposing trend in H4K20me1 and H4K20me3
levels observed during C12C12 differentiation, which occurs
gradually over several days in DM [21]. As a result, the precocious
expression of Myog induced by exogenous SUV420H1_i2 (and to
a lesser extent by SUV420H2) may derive from its suppression of
H4K20me1 levels. In dividing cells, this modification normally
increases steadily through S-phase before undergoing a marked
elevation during mitosis [9], and its catalysis by PR-Set7 is
required for progression through S-phase and G2/M
[12,13,14,15,16,17]. Consistent with this idea, PR-Set7 knock-
down and the resulting decrease in levels of H4K20me1 caused
spontaneous differentiation of K562 myelogenous leukemia cells
[36]. Collectively, these data suggest that cell cycle-associated
changes in histone H4-K20 methylation play an important role in
exit from the cell cycle and initiation of differentiation.
In contrast to the acute effect of SUV420H1_i2 expression,
SUV420H2 enriched for Myog-positive cells over the entire course
of differentiation (2.8-fold higher by day 5). This was accompanied
by increased localization of this enzyme to PCH, which correlates
with the gradual increase in H4K20me3 observed in these regions
during myogenesis in vivo and in situ [21]. From a mechanistic
standpoint, these observations indicate SUV420H2 promotes the
myogenic program through the catalysis of H4K20me3 in regions
of PCH. This behavior is clearly different from the inhibition of
C2C12 differentiation that occurs upon expression of SUV39H1
[37] and EZH2 [38]. Moreover, transgenic mice over-expressing
Suv39h1 display impaired erythroid differentiation both in vivo and
when cells are cultured ex vivo where they become immortalized
[39], and EHZ2 has an essential role in maintaining the
pluripotent/undifferentiated state of embryonic stem cells [40,41,
42]. This suggests their methylated products, H3K9me3 for
SUV39H1 [43,44] and H3K27me2/3 for EZH2
[45,46,47,48,49], function differently than SUV420H and
H4K20me3 in regulating differentiation. Unlike H3K9me3 and
H3K27me3, which have been associated with repression of
Figure 7. Affect of SUV420H expression on myogenic differentiation in C2C12 cells. The C2C12 myoblast cell line was transfected with
expression plasmids for SUV420H1_i2 (A) and SUV420H2 (B). Transfected cells were monitored for expression of endogenous Myogenin (Myog) and
exogenous SUV420H proteins by co-immunofluorescence on day 0 (d0; 24 hr post-transfection) in GM and days 1 through 5 (d1-d5) in DM. Graphs
indicate the percentage of cells expressing Myog (detected with the F5D monoclonal antibody; open bars) and the percentage of SUV420H-
expressing cells positive (+ve) for Myog (gray bars). The values listed below each graph depict the ratio of SUV420H/Myog double positive cells to
cells singly positive for Myog at each day. Error bars represent standard deviation from three independent experiments and significant differences are
noted between the d5 values for Myog and Myog/SUV420H (brackets), and when comparing Myog/SUV420H1_i2 to Myog/SUV420H2 (asterisks). The
compiled data is based on the analysis of 56,939 (SUV420H1_i2) and 64,464 cells (SUV420H2).
doi:10.1371/journal.pone.0014447.g007
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obvious association with active or repressed promoters [50]. Given
the ability of H4K20me3 to induce compaction of in vitro
reconstituted chromatin [51], this modification could also serve
a unique role in chromatin structure that is not conferred by
H3K9me3 or H3K27me3.
The distinct roles for SUV39H and SUV420H proteins are
somewhat surprising given localization to PCH by the latter is
dependent on H3K9me3 catalyzed by the former [10]. Never-
theless, we did not observe a correlation between H4K20me3 and
H3K9me3 levels during differentiation, and the two modifications
display distinct dynamics during embryogenesis [21]. Microarray
analyses in C2C12 cells also establish that these KMTs display
different expression profiles—SUV420H1 and SUV420H2 stay
constant or increase, while EZH2 and SUV39H1 decline [52,53],
which has also been independently established for the latter two
enzymes [37,38,54,55]. Moreover, exogenous expression of HP1
proteins (a, b, and c) inhibits myogenic differentiation in the
C2C12 model system [56]. It therefore appears that a basal level of
H3K9me3 may be required for initial SUV420H recruitment, but
the ensuing catalysis of H4K20me3 maintains the differentiated
state without a parallel increase in H3K9me3. Lastly, it is
noteworthy that H4K20me3 accumulates in ageing tissue of
multiple lineages [22] and it will therefore be important to be
determine if SUV420H/H4K20me3 function in a similar manner
in other models of cell differentiation.
The accumulation of histone H4K20me3 during differentiation
and ageing, and the behavior of SUV420H proteins described in
the present study are relevant to understanding the role of this
modification in cancer. In particular, a number of studies indicate
that H4K20me3 levels decline in tumor samples and, more
recently, in preneoplastic lesions [23,24,25]. Coincident with this
change in H4K20me3, levels of SUV420H2 are reduced [24,25],
which draws an important parallel with the affect of this enzyme
on differentiation. Specifically, the unique ability of SUV420H2,
when compared to SUV420H1, to enhance myogenic differenti-
ation suggests its decrease may contribute to de-differentiation or
an inability to maintain the differentiated state. Moreover, given
the dynamics of histone H4 K20 methylation and their
importance to cell cycle progression [9,12,13,14,15,16,17], any
imbalance may contribute to the deregulated cell cycle control that
characterizes oncogenic transformation [57,58]. Taken together
with the observation that attenuation of SUV420H activity leads
to compromised genomic integrity [11,18,27,59], perturbations in
histone H4K20 methylation have the capacity to influence
multiple aspects of cancer cell biology.
Supporting Information
Figure S1 Analysis of evolutionary conservation at the
SUV420H1 locus. A) Multispecies alignment of the exon 9-intron 9
junction. Alignments were carried out using genomic sequences from
36 metazoan species, all of which had the splice donor, with a single
occurrence of an atypical ‘GA’ donor site. Only 4 species lacked the
conserved stop codon, but each contained an in-frame stop codon that
added anywhere from 4-20 amino acid residues. B) Genome
alignments were carried out using the Evolutionarily Conserved
Regions (ECR) browser of the NCBI DCODE package (http://
ecrbrowser.dcode.org) and human SUV420H1 (chr11:67680083-
67737360) as the query sequence. Output from the ECR browser is
shown for a region of the human SUV420H1 gene spanning exons 5 to
10 (exons are depicted in blue, introns in pink, UTRs in yellow,
repetitive elements in green, and intergenic regions in red). The
sequence 39 of exon 9, is annotated as a UTR and shows a higher
degree of conservation than regions downstream of other exons
(including exons 1-4, not shown). Alignments include the correspond-
ing region from the genomes of Rattus norvegicus, Mus musculus, Bos
taurus, Canis familiaris,a n dRhesus macaques. C) Expressed sequence tags
for the SUV420H1 isoforms. A 30aa segment at the C-terminus of
each SUV420H1 isoforms was used to analyze the mouse and human
components of the Expressed Sequence Tag (EST) database using
tBlastn. The accession numbers and position of the coded sequence
within the EST are shown. In each case, the presence of the stop
codon was verified and the source tissue or cell line is indicated.
Found at: doi:10.1371/journal.pone.0014447.s001 (8.14 MB TIF)
Figure S2 Affect of exogenous GFP expression on H4K20me1
and H4K20me3. C3H 10T1/2 cells were transfected with the
pEGFP-N1 expression plasmid (Clontech) and processed for
immunofluorescence using antibodies specific for H4K20me1 (A)
or H4K20me3 (B). In each case, the upper panel shows a
representative micrograph of adjacent cells, where the cell on the
leftexpressesGFP.ThelowerpanelsdepictstainingwithH4K20me1
orH4K20me3 antibodies.Enrichment of H4K20me1 on the inactive
X chromosome (Xi) is indicated. Scale bar is 10 mm.
Found at: doi:10.1371/journal.pone.0014447.s002 (8.38 MB TIF)
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